Rentokil Initial (LON:RTO – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Jefferies Financial Group in a report issued on Thursday, MarketBeat reports. They presently have a GBX 600 ($7.47) price target on the stock. Jefferies Financial Group’s price objective would suggest a potential upside of 41.94% from the company’s current price.
Separately, Royal Bank of Canada upped their price objective on shares of Rentokil Initial from GBX 575 ($7.16) to GBX 590 ($7.34) and gave the company an “outperform” rating in a report on Tuesday, March 12th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of GBX 636.80 ($7.93).
Rentokil Initial Stock Performance
Insiders Place Their Bets
In other news, insider Andy M. Ransom sold 464,245 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of GBX 489 ($6.09), for a total value of £2,270,158.05 ($2,826,040.15). Corporate insiders own 1.10% of the company’s stock.
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Recommended Stories
- Five stocks we like better than Rentokil Initial
- What is a SEC Filing?
- Comprehensive Analysis of PayPal Stock
- Health Care Stocks Explained: Why You Might Want to Invest
- Intuitive Surgical Stock Can Trend Much Higher This Year
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.